메뉴 건너뛰기




Volumn 1, Issue 2, 1999, Pages 109-116

Prophylactic efficacy of lithium administered every second day: A WHO multicentre study

Author keywords

Bipolar disorder; Dosing schedule; Lithium; Lithium every second day; Prophylaxis

Indexed keywords

LITHIUM DERIVATIVE; TRANQUILIZER;

EID: 0033301365     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.1999.010208.x     Document Type: Article
Times cited : (6)

References (15)
  • 3
    • 0021062911 scopus 로고
    • Decreasing lithium dosage reduces morbidity and side effects during prophylaxis
    • Coppen A, Abou-Saleh M, Milln P, Bailey J, Wood K. Decreasing lithium dosage reduces morbidity and side effects during prophylaxis. J Affect Disord 1983; 5: 353-362.
    • (1983) J Affect Disord , vol.5 , pp. 353-362
    • Coppen, A.1    Abou-Saleh, M.2    Milln, P.3    Bailey, J.4    Wood, K.5
  • 4
    • 0023730084 scopus 로고
    • Prospective studies on a lithium cohort: 1. General features. 2. Renal function. Water and electrolyte metabolism. 3. Tremor, weight gain, diarrhoea, psychological complaints
    • Vestergaard P, Schou M. Prospective studies on a lithium cohort: 1. General features. 2. Renal function. Water and electrolyte metabolism. 3. Tremor, weight gain, diarrhoea, psychological complaints. Acta Psychiatr Scand 1988; 78: 421-441.
    • (1988) Acta Psychiatr Scand , vol.78 , pp. 421-441
    • Vestergaard, P.1    Schou, M.2
  • 6
    • 0022994295 scopus 로고
    • Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: A prospective study
    • Maj M, Starace F, Nolfe G, Kemali D. Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study. Pharmacopsychiatry 1986; 19: 420-423.
    • (1986) Pharmacopsychiatry , vol.19 , pp. 420-423
    • Maj, M.1    Starace, F.2    Nolfe, G.3    Kemali, D.4
  • 7
    • 0019472916 scopus 로고
    • Functional and structural rat kidney changes caused by peroral or parenteral lithium treatment
    • Plenge P, Mellerup ET, Norgaard J. Functional and structural rat kidney changes caused by peroral or parenteral lithium treatment. Acta Psychiatr Scand 1981; 63: 303-313.
    • (1981) Acta Psychiatr Scand , vol.63 , pp. 303-313
    • Plenge, P.1    Mellerup, E.T.2    Norgaard, J.3
  • 9
    • 0019995104 scopus 로고
    • Lithium treatment regimen and renal water handling: The significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens
    • Schou M, Amdisen A, Thomsen K, Vestergaard P, Hetmar O, Mellerup ET, Plenge P, Rafaelsen OJ. Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology 1982; 77: 387-390.
    • (1982) Psychopharmacology , vol.77 , pp. 387-390
    • Schou, M.1    Amdisen, A.2    Thomsen, K.3    Vestergaard, P.4    Hetmar, O.5    Mellerup, E.T.6    Plenge, P.7    Rafaelsen, O.J.8
  • 10
    • 0022523028 scopus 로고
    • Lithium and the kidney: Is one daily dose better than two?
    • Plenge P, Mellerup ET. Lithium and the kidney: is one daily dose better than two? Compr Psychiatry 1986; 27: 336-342.
    • (1986) Compr Psychiatry , vol.27 , pp. 336-342
    • Plenge, P.1    Mellerup, E.T.2
  • 13
    • 0017736703 scopus 로고
    • Serum level monitoring and clinical pharmacokinetics of lithium
    • Amdisen A. Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet 1977; 2: 73-92.
    • (1977) Clin Pharmacokinet , vol.2 , pp. 73-92
    • Amdisen, A.1
  • 14
    • 0346250576 scopus 로고
    • Clinically important side effects of long term lithium treatment: A review
    • Vestergaard P. Clinically important side effects of long term lithium treatment: a review. Acta Psychiatr Scand [suppl] 1983; 67: 11-36.
    • (1983) Acta Psychiatr Scand [Suppl] , vol.67 , pp. 11-36
    • Vestergaard, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.